LIFR, Recombinant, Mouse (Leukemia Inhibitory Factor Receptor, LIF Receptor, LIF-R, D-factor/LIF Receptor, CD118)

Leukemia Inhibitory Factor Receptor alpha (LIF R-alpha), also known as LIFR beta and CD118, is a 190kD type I transmembrane protein in the Interleukin-6 receptor family. Members of this family mediate the biological effects of Cardiotrophin-1, CLC, CNTF, IL-6, IL-11, IL-27, and Oncostatin M. Mature mouse LIF R-alpha consists of a 785aa extracellular domain (ECD) with two cytokine receptor homology domains, one WSxWS motif, and three fibronectin type III repeats, followed by a 25aa transmembrane segment and a 239aa cytoplasmic domain. Within the ECD, mouse LIF R-alpha shares 73% and 90% aa sequence identity with human and rat LIF R-alpha, respectively. Alternative splicing generates a 90kD soluble form of the mouse LIF R-alpha ECD. LIF R-alpha binds the pleiotropic cytokine LIF with low affinity, and the soluble isoform retains LIF-binding activity. Binding affinity is increased by the ligand-induced association of LIF R-alpha with the signal transducing subunit gp130. The LIF R-alpha/gp130 receptor complex also transduces Oncostatin M signals, although LIF R-alpha alone does not interact with Oncostatin M. gp130 associates with different ligand-specific receptors to form signaling receptor complexes for the other IL-6 family ligands. The CNTF receptor is a ternary complex that contains CNTF R-alpha and gp130 as well as LIF R-alpha. LIF R-alpha is widely expressed, and LIF induces the proliferation, differentiation, and activation of cells in many tissues. In particular, LIF R-alpha plays an important role in several aspects of early pregnancy such as blastocyst implantation in the uterus.\n\nSource: \nMurine myeloma cell line, NS0-derived Leu44-Ser828, with a C-terminal 6-His tag.\n\nMolecular Mass:\nPredicted: 89.4kD\nObserved: 125-140kD by SDS-PAGE (reducing conditions)\n\nActivity:\nMeasured by its ability to inhibit LIF-dependent proliferation of TF-1 human erythroleukemic cells. The ED50 for this effect is typically 0.8-4ug/ml.\n\nEndotoxin Level: (same/less than)1EU/1ug (LAL)\n\nStorage and Stability:\nLyophilized powder may be stored at -20 degrees C. Stable for 12 months at -20 degrees C and lower. Reconstituted product is stable for 3 months under sterile conditions at -20 degrees C and lower. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Prices direct from United States Biological

Quick response times

Exclusive Biosave savings/discounts